NATCO Pharma shares tumbled 10% on Friday, extending a two-day slump to 28% after weak Q3 results and a target price cut by ...

Telangana: Natco Pharma has announced the resignation of Dr Pavan Ganapati Bhat as Director & Executive Vice President ...

Hyderabad: NATCO Pharma Limited has announced final approval of its Abbreviated New Drug Application (ANDA) for Bosentan ...

NATCO Pharma is a smallcap company. It is a constituent of BSE 500 index. The pharma stock crashed 20 per cent after it ...

Stock analysts noted Natco Pharma’s missed consensus Q3 estimates on both revenue and Ebitda margin fronts due to lack of ...

Natco Pharma has received U.S. Food and Drug Administration final approval for Bosentan tablets for oral suspension, 32mg, its generic version of Actelion Pharmaceuticals US Inc.’s pulmonary ...

Global pharma major Lupin Limited (Lupin) and its alliance partner Natco Pharma Limited (Natco), announced that they have received an approval from the United States Food and Drug Administration (FDA) ...

Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is ...

Hyderabad: Global pharma major Lupin Limited (Lupin) and its alliance partner Natco Pharma Limited (Natco) have announced that they received the approval from the United States Food and Drug ...

Drug maker Natco Pharma on Monday, February 10, announced securing the final approval from the United States Food and Drug Administration (USFDA) for its Bosentan tablets, which are used in treating ...

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo The U.S. Food and Drug Administration ...